SEATTLE, WA – Immunex Corporation (Nasdaq: IMNX) and Wyeth-Ayerst Laboratories, a division of American Home Products (NYSE: AHP) announced today that the U.S. Food and Drug Administration (FDA) has ...

LOS ANGELES, Nov 7 (Reuters) - Early results from an ongoing study showed that people with newly diagnosed rheumatoid arthritis were more likely to reach clinical remission with Amgen Inc and Wyeth's ...

THOUSAND OAKS, Calif., and COLLEGEVILLE, Pa., June 20, 2003 – Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced results of a new study assessing the ...

KENILWORTH, N.J. & SEOUL, South Korea--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd. today announced that pivotal Phase 3 clinical studies of SB4, ...

COLLEGEVILLE, Pa., and THOUSAND OAKS, Calif. A study has found that when given early in the onset of rheumatoid arthritis in combination with other therapies, Amgen’s drug Enbrel (etanercept) can ...

available with approved dosing regimens for children and adolescents.

Whether starting or maintaining treatment, the Embark App has multiple features that can help patients on ENBREL throughout their treatment experience. As the healthcare industry continues to evolve ...